427 filings
6-K
SVA
Sinovac Biotech, Ltd.
29 Apr 24
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
6:12pm
20-F
2023 FY
SVA
Sinovac Biotech, Ltd.
Annual report (foreign)
29 Apr 24
4:30pm
SC TO-T/A
SVA
Sinovac Biotech, Ltd.
15 Mar 24
Third party tender offer statement (amended)
6:18pm
8-A12B/A
SVA
Sinovac Biotech, Ltd.
21 Feb 24
Registration of securities on exchange (amended)
6:09am
6-K
SVA
Sinovac Biotech, Ltd.
21 Feb 24
Current report (foreign)
6:02am
SC TO-T/A
i8zv0o43ctl53
2 Feb 24
Third party tender offer statement (amended)
11:19am
SC 14D9
9hcskxte
18 Jan 24
Tender offer solicitation
7:13am
SC TO-T
07c8rn7qbusu86j
8 Jan 24
Third party tender offer statement
4:46pm
UPLOAD
jcd8 5wvba6xcguo
10 Oct 23
Letter from SEC
12:00am
CORRESP
h9sp tgpv5
5 Oct 23
Correspondence with SEC
12:00am
SC TO-T/A
neu 998hyvm
3 Oct 23
Third party tender offer statement (amended)
9:39am
6-K
v58wkq9gei8u
11 Sep 23
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
6:16am
UPLOAD
8k5g5
8 Sep 23
Letter from SEC
12:00am
SC 14D9
wsk5h6e0o7xhxo
5 Sep 23
Tender offer solicitation
7:04am
CORRESP
hjw pli5i
1 Sep 23
Correspondence with SEC
12:00am
6-K
e6rlu7jjq
29 Aug 23
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
6:05am
6-K
45wo wg93lhl23gkxe
28 Aug 23
Sinovac Announces Change of Legal Representative of Sinovac Beijing
9:12am
SC TO-T
kzp2or2
24 Aug 23
Third party tender offer statement
6:10pm
6-K
pje2wtbu1 vf
15 Aug 23
SINOVAC Reports Unaudited First Half of 2023 Financial Results
6:27am
UPLOAD
s22gnv 973cs4
21 Jul 23
Letter from SEC
12:00am